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THE LEGAL STATUS OF CANNABIDIOL OIL AND THE 
NEED FOR CONGRESSIONAL ACTION 
SHELLY B. DEADDER, J.D.1
INTRODUCTION
Over 65 million people worldwide suffer from epileptic conditions 
and approximately one-third of these individuals have medically    
refractory   epilepsy, meaning they are unresponsive to medical    
therapy.2  Dravet     syndrome (DS), also known as severe myoclonic 
epilepsy in infancy, is one type of medically refractory epilepsy that 
³OHDGVWRLQWHOOHFWXDOGLVDELOLW\PRWRULPSDLUPHQWDQGGHSHndence in 
adultKRRG´3  Approximately one child in every 40,900 is born with 
this catastrophic disease, most commonly the result of a mutation in 
the SCN1A sodium channel gene.4  Typically, the first seizure occurs 
GXULQJ WKH FKLOG¶V ILUVW \HDU RI OLIH DQG is mistakenly diagnosed as 
³DFFLGHQWDO´ RU IHYHU UHODWHG KRZHYHU ZLWKLQ ZHHNV RU PRQWKV
additional seizures occur.5  Between one and five years of age, up to 
                                                                                                                          
1.Shelly DeAdder is an Assistant Professor of Law in the Legal Writing Program at 
North Carolina Central University School of Law (NCCU Law) in Durham, North 
Carolina.  Prior to joining the faculty at NCCU Law, Professor DeAdder was a staff 
attorney at the North Carolina General Assembly where she assisted in drafting 
House Bill 1220 (Session Law 2014-53), which decriminalized the possession of 
CBD oil for the limited purpose of treating intractable epilepsy.  Nothing in this 
article is the product of confidential communications with legislators or legislative 
staff.  Special thanks to Jeremy Locklear (NCCU Law, Class of 2016) for his re-
search assistance; attorneys Bill Patterson, Rod Kight, and Wyatt Orsbon for their 
assistance with editing; and to the legal writing team at NCCU Law for their con-
tinuous support and friendship. 
2.Craig A. Press et al., Parental Reporting of Response to Oral Cannabis Extracts 
for Treatment of Refractory Epilepsy, 45 EPILEPSY & BEHAVIOR 49, 49 (2015). 
3.Elaine C. Wirrell et al., Stripentol in Dravet Syndrome: Results of a Retrospective 
U.S. Study, 54(9) EPILEPSIA 1595, 1595 (2013). 
4. Id.
5.Charlotte Dravet, The Core Dravet Syndrome Phenotype, 52 EPILEPSIA (Suppl. 2) 
3, 4 (2011). 
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five different types of seizures emerge of varying duration and       
intensity, coinciding with developmental delays and behavioral     
regression.6  After age five, the disease tends to stabilize and seizures 
become less frequent, but many children have already suffered     
irreparable mental and physical impairments, including the inability 
to construct simple sentences, undeveloped fine motor skills, and 
poor hand-eye coordination.7
Studies indicate that the prognosis is improved if seizure control is       
established at a young age.8  However, DS is one of the most               
pharmacoresistant forms of epilepsy; various pharmaceuticals have 
been prescribed alone and in combination, but none have been able to 
eliminate the seizures these children endure.9  A promising treatment 
using cannabidiol (CBD) oil, derived from industrial hemp, offers 
hope to many of these children and their families.  The problem is 
that the federal Controlled Substances Act (CSA), enforced by the 
Department of Justice (DOJ) and the Drug Enforcement                
Administration (DEA), classifies domestically grown industrial hemp 
as a Schedule 1 controlled substance.10  Consequently, with limited 
exceptions, American companies that produce CBD oil with          
domestically grown industrial hemp, and parents who administer it to 
their children, are in violation of federal law. 
This article examines the need to enact federal legislation to         
legalize the domestic production of industrial hemp and CBD oil.  
Part One explores the recent surge in the use of CBD oil to reduce 
seizures.  Part Two examines the inconsistencies between federal 
statutes, case law, and federal enforcement policy, as well as the   
various legislative responses from the states.  Part Three discusses 
                                                                                                                          
6.Id. at 4, 6. 
7.Id. at 6. 
8.See Mari Akiyama et al., A Long-term Follow-up Study of Dravet Syndrome Up 
to Adulthood, 51(6) EPILEPSIA 1043, 1051 (2001). 
9.Catherine Chiron et al., The Pharmacologic Treatment of Dravet Syndrome, 52 
EPILEPSIA (Suppl. 2) 72, 72-73 (2011). 
10.21 U.S.C. § 802(16) (2012) (defining marijuana); 21 U.S.C. § 812(c)(10) (2012) 
(designating any part of the plant Cannabis sativa as a Schedule 1 controlled sub-
stance); 21 C.F.R. § 1308.11(d)(23), (31).  The CSA classifies all drugs within five 
VFKHGXOHV86&D'UXJVSODFHGLQ6FKHGXOHKDYH³QRFXr-
UHQWO\DFFHSWHGPHGLFDOXVHLQWUHDWPHQWLQWKH8QLWHG6WDWHV´DQGDKLJKSRWHntial 
for abuse.  21 U.S.C. § 812(b). 
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the resulting limitations on research efforts.  Finally, Part Four      
recommends a federal legislative solution. 
PART 1: THE RISE OF CBD OIL
In 2006, Paige Figi gave birth to two healthy twin girls, Charlotte 
DQG&KDVH)LJL7KH\ZHUHKDSS\³HDV\´EDELHV11  The twins were 
developing normally, but when Charlotte was around three months 
old, she had her first seizure, which was diagnosed as fever related, a 
³IOXNH´12  Soon thereafter, Charlotte began having more seizures, 
and, by age two, the seizures had become constant.13  According to 
KHUPRWKHU³VKHZDVVOLSSLQJDZD\´14  In addition to the crippling 
seizures and declining cognitive development, she began having    
behavioral problems±attention deficit, hyperactivity, and self-
injury.15 Charlotte was diagnosed with DS and began pharmaceutical 
regiments, dietary alterations, and even acupuncture, but nothing 
controlled the seizures.16  In fact, some of the drugs she was           
prescribed almost killed her.17  By age five, Charlotte was having 
three hundred seizures per week, approximately two every hour.18
She was virtually catatonic, and, at one point, she was placed in a 
medically induced coma so her fragile brain and body could           
recuperate.19
Paige and her husband Matt had given up hope that modern       
PHGLFLQH FRXOG VDYH WKHLU GDXJKWHU¶V OLIH20 While deployed in      
Afghanistan, Matt saw a video online of a young boy with DS being 
treated with marijuana.21  The boy had been seizure-free for four 
                                                                                                                          
11.WEED: A Dr. Sanjay Gupta Investigation (CNN television broadcast Aug. 11, 
2013), available at http://www.cnn.com/TRANSCRIPTS/1308/11/se.01.html 
EURDGFDVW WUDQVFULSW RI 'U *XSWD¶V LQWHUYLHZV ZLWK WKH )LJLV DQG WKH 6WDQOH\
brothers). 
12. Id. 
13. Id.
14. Id.
15. Id.
16. Id.
17. Id.
18. Id.
19. Id.
20. Id.
21. Id.
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days.22  Desperate for help, Matt and Paige took Charlotte to        
Colorado where medical marijuana had been legalized.23  At that 
time, Colorado required a prescription for marijuana from two      
physicians, and the Figis had difficulty finding two physicians who 
would prescribe maULMXDQDWRDFKLOGRI&KDUORWWH¶VDJH24
However, while in Colorado, they were introduced to Joel and Josh 
Stanley, two of six Stanley brothers, who had genetically cultivated 
industrial hemp that was high in CBD, the non-psychoactive compo-
nent of the plant, and low in tetrahydrocannabinol (THC), the      
psychoactive component of the plant.25  The Stanley brothers began 
their marijuana business in 2008, producing plants high in THC that 
were intended to produce the psychoactive effect typically associated 
with smoking marijuana recreationally.26  They experimented with 
the high-CBD, low-THC variety of plant, producing an oil they 
FDOOHG ³+LSSLH¶V 'LsDSSRLQWPHQW´ EHFDXVH RI LWV QRQ-psychoactive 
effect.27  In 2012, they provided their CBD oil to Charlotte Figi and, 
DIWHU MXVW D IHZ GRVHV KHU VHL]XUHV ³DOO EXW VWRSSHG´28 After           
approximately two years on a feeding tube, suffering more than 300 
seizures a week, Charlotte began to walk, talk, and feed herself.29
CurUHQWO\ VKH WDNHV GURSV RI &%' RLO GDLO\ DQG ³LV QHDUO\ IUHH RI
VHL]XUHV´30
After seeing the effects of their CBD oil on Charlotte Figi, the 
Stanleys renamHG LW ³&KDUORWWH¶V:HE´31  Soon thereafter, multiple 
television broadFDVWV GHWDLOLQJ &KDUORWWH¶V VWRU\ ZHUH UHOHDVHG DQG
IDPLOLHV IURP DURXQG WKH FRXQWU\ ZDQWHG WR SXUFKDVH &KDUORWWH¶V
                                                                                                                          
22. Id. 
23. Id.
24. Id.
25. Id. 
26.Dave Phillips, Bid to Expand Medical Marijuana Business Faces Federal    
Hurdles, N.Y. TIMES, Aug. 23, 2014, at A14. 
27. Id. 
28. Id. 
29.WEED, supra note 11. 
30.See Phillips, supra note 26.
31.Joel Warner, &KDUORWWH¶V:HE8QWDQJOLQJRQHRI&RORUDGR¶V%LJJHVW&Dnnabis 
Success Stories, WESTWORD (Dec. 3, 2014), 
http://www.westword.com/news/charlottes-web-untangling-one-of-colorados-
biggest-cannabis-success-stories-6050830 (last visited Mar. 5, 2016). 
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Web to treat epilepsy and other diseases.32  Unfortunately, possessing 
CBD oil is, according to the DEA, a federal crime. 
PART 2: THE FEDERAL PROHIBITION OF CBD OIL AND THE 
INCONSISTENCIES BETWEEN STATUTES, CASE LAW, AND POLICY
The Botany of Industrial Hemp and the Prohibition on Its Domestic 
Growth 
DEA spokeswoman Dawn DeardHQSXWLWEHVWZKHQVKHVDLG³$Q\
chemical that comes from the plant [Cannabis sativa] is still a       
controlled substance.  When we get into hemp, it gets a little squishy, 
EXWLWVWLOOLVLOOHJDO´33 ³$OLWWOHVTXLVK\´LVDQDFFXUDWHLIFROORTXLDO
description of the ambiguous legal status of products derived from 
industrial hemp.  Moreover, Ms. Dearden touches on a point that 
mars the discussion of legalizing CBD oil at the federal level ± its 
association with marijuana. 
&%'RLOVXFKDV&KDUORWWH¶VWeb, is derived from industrial hemp, 
not marijuana.34  To be clear, both the marijuana plant and the       
industrial hemp plant come from the same botanical species,        
Cannabis sativa, which is within the broader genus, Cannabis.35  The 
Cannabis sativa plant has trichomes, which are small hairs growing 
from the epidermis of the plant.36  These hairs contain two organic 
compounds, phenols and terpenes.37 ³$V SKHQROV DQG WHUSHQHV
migrate upward from the base of a trichome to the bud at its tip, a 
series of chemical reactions occur that convert these simple basic 
                                                                                                                          
32. Id.
33.Phillips, supra note 26 (internal quotation marks omitted).
34.Id.  That is not to say that it cannot be produced from marijuana, but it does not 
have to be, and currently, it is being derived from industrial hemp. 
35.Lyle E. Craker and Zoë Gardner, The Botany of Cannabis, in THE POT BOOK 35, 
36 (Julie Holland, ed. 2010) (describing the genus, Cannabis); see also Robert C. 
Clark & David Paul Watson, Botany of Natural Cannabis Medicines, in CANNABIS 
AND CANNABINOIDS PHARMACOLOGY, TOXICOLOGY, AND THERAPEUTIC 
POTENTIAL 3, 10 (Franjo Grotenhermen & Ethan Russo, eds. 2002) (noting that 
while some experts recognize three species of Cannabis (Cannabis sativa, Canna-
bis indica, and Cannabis ruderalis), Cannabis sativa ³UHSUHVHQWV WKH ODrgest and 
PRVWGLYHUVHWD[RQ´
36.DAVID E. NEWTON, MARIJUANA 6 (2013). 
37.Id. at 7. 
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comSRXQGVLQWRDODUJHYDULHW\RIPRUHFRPSOH[FRPSRXQGV´38
While more than 400 chemical compounds can be extracted from 
Cannabis sativa, 66 of them are unique to that plant.39  These 66 
chemicals are called cannabinoids.40  Psychoactive THC, and       
non-psychoactive CBD, are the most abundant cannabinoids.41
Although the flowering portion of the plant does not contain         
trichomes, it nevertheless has a high concentration of cannibinoids, 
³SUREDEO\ EHFDXVH RI WKH DFFXPXODWLRQ RI UHVLQ VHFUHWHG E\ WKH
supporting bracteole (the small leaf-like part beORZWKHIORZHU´42
It is the near absence of THC that distinguishes the industrial hemp 
plant from the marijuana plant.43 ³2YHUWhe centuries, the hemp plant 
has been crossbred to have low concentrations of THC, presently 
about 0.3 percent.  By contrast, cannabis plants raised for the        
production of marijuana have much higher concentrations of THC, 
ranging from about 2 to as much as 20 perFHQW´44
The significant difference in THC content in industrial hemp and 
marijuana plants is irrelevant to federal laws; plants containing any 
amount of THC are illegal.45  The CSA, passed in 1970, defines    
marijuana as follows: 
7KHWHUP³PDULKXDQD´PHDQVDOOSDUWVRIWKHSODQW&DQQDELVVDWLYD
L., whether growing or not; the seeds thereof; the resin extracted 
from any part of such plant; and every compound, manufacture, salt, 
derivative, mixture, or preparation of such plant, its seeds or resin. 
Such term does not include the mature stalks of such plant, fiber    
produced from such stalks, oil or cake made from the seeds of such 
plant, any other compound, manufacture, salt, derivative, mixture, or 
preparation of such mature stalks (except the resin extracted        
                                                                                                                          
38. Id.
39. Id. 
40. Id. 
41.JANET E. JOY ET AL., MARIJUANA AND MEDICINE 3 (1999). 
42.Id. at 25-26. 
43.NEWTON, supra note 36, at 11. 
44.Id. ,QGXVWULDOKHPSKDVEHHQFDOOHG³PDULMXDQD¶V VREHUFRXVLQ´EHFDXVHRI LWV
low concentration of THC. JONATHAN P. CAULKINS ET AL., MARIJUANA 
LEGALIZATION 225 (2012). 
45.NEWTON, supra note 36, at 11. 
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therefrom), fiber, oil, or cake, or the sterilized seed of such plant 
which is incapable of germination.46
Despite its convoluted language, it is clear that this definition does 
not offer a distinction between high and low THC varieties of the 
Cannabis sativa plant.47
This has not stopped some from arguing that industrial hemp is   
excluded from this definition.48  This argument was rejected in    
Monson v. DEA, in which the Eighth Circuit examined a North      
Dakota law enacted in 2007 permitting the cultivation of industrial 
hemp containing no more than 0.3 percent THC.49  After obtaining a 
license to grow industrial hemp under North Dakota law, but before 
planting it, the plaintiffs sought a judicial declaration that the CSA 
does not apply to industrial hemp.50  The court examined the CSA 
DQGVWDWHG³7KH&6$HVWDEOLVKHVDFRPSUHKHQVLYHIHderal system to 
regulate the manufacture and distribution of controlled substances, 
PDNLQJ LW XQODZIXO WR µPDQXIDFWXUH GLVWULEXWH RU GLVSHQVH¶ DQ\
controlled subVWDQFHµ>H@[FHSWDVDXWKRUL]HGE\¶WKH$FW´51  The term 
³PDQXIDFWXULQJ´ DOVR LQFOXGHV ³SURGXFWLRQ´ DQG ³SURGXFWLRQ´
LQFOXGHV ³SODQWLQJ´ ³FXOWLYDWLQJ´ ³JURZLQJ´ RU ³KDUYHVWLQJ´ D
controlled substance.52 7KHFRXUWKHOG WKDW WKH&6$¶s definition of 
marijuana includes all varieties of the plant Cannabis sativa, and, 
consequently, industrial hemp may not be grown domestically.53  It 
follows that if Cannabis sativa may not be grown domestically, then 
                                                                                                                          
46.86&7KH³/´LQWKHVWDWXWHUHIHUVWR/LQQDHXV¶V\VWHPRIEo-
tanical classification. See United States v. King, 485 F.2d 353, 360±61 (10th Cir. 
1973). 
47.21 U.S.C. § 802(16).
48.See Courtney N. Moran, Industrial Hemp: Canada Exports, United States Im-
ports, 26 FORDHAM ENVTL. L. REV. 383, 406-07 (2015). 
49.Monson v. DEA, 589 F.3d 952, 955 (8th Cir. 2009) (examining N.D. Cent. 
Code §§ 4-41-01±4-41-03 (2007)). 
50. Id.
51.Id. at 956 (quoting 21 U.S.C. § 841(a)(1)). 
52.Id. TXRWLQJ86& GHILQLQJ ³PDQXIDFWXULQJ´ DQG86&
802(22) (definLQJ³SURGXFWLRQ´
53.Id. at 964; accord New Hampshire Hemp Council, Inc. v. Marshall, 203 F.3d 1, 
8 (1st Cir. 2000) (holding that the CSA prohibits the domestic growth of any form 
of Cannabis sativa, including industrial hemp).  The DEA may issue a license for 
the growth of industrial hemp pursuant to U.S.C. §§ 822-832 (2012), but these 
licenses are rarely given.  Moran, supra note 48, at 407. 
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CBD oil may not be produced domestically.54 +HQFH WKH '($¶V
position that all chemicals that come from the plant Cannabis sativa,
including CBD, are illegal. 
Federal Government Nonenforcement with Regard to Domestic 
Growth of Cannabis Sativa and the Various Legislative Responses 
from the States 
If Cannabis sativa may not be legally grown domestically in any 
form, then why were the Stanley brothers not prosecuted for growing 
it and providing its oil to Charlotte Figi in 2012?  The answer is a 
federal government policy of nonenforcement.  The legal status of 
Cannabis sativa LQDQ\IRUP³UHPDLQVWKHVDPHDVLWKDVEHHQVLQFH
1970: Possession, cultivation, and distribution are categorically     
IRUELGGHQ DQG VXEMHFW WR FULPLQDO SHQDOWLHV´55 While the               
federal government has not sought a statutory change, the Obama 
adPLQLVWUDWLRQ³KDVDGRSWHGDSXEOLFSRVLWLRQRIWDFLWHQFRXUDJHPHQW
for state legalization, premised on a baseline of federal                  
QRQHQIRUFHPHQW´56
On October 19, 2009, Deputy Attorney General David G. Ogden 
issuHG D PHPRUDQGXP WR ³VHOHFWHG´ 8QLWHG 6WDWHV $WWRUQH\V WKH
2JGHQ 0HPR LQ ZKLFK KH VWDWHG ³7KH 'HSDUWPHQW RI -XVWLFH LV
committed to the enforcement of the Controlled Substances Act in all 
6WDWHV´57  However, the Ogden Memo goes on to discuss the limited 
resources of the federal government and further provides: 
The prosecution of significant traffickers of illegal drugs, including 
marijuana, and the disruption of illegal drug manufacturing and     
trafficking networks continues to be a core priority in the              
DepartPHQW¶VHIIRUWVDJDLQVWQDUFRWLFVDQGGDQJHURXVGUXJVDQG WKH
                                                                                                                          
54.It was once legal to grow industrial hemp in the United States.  Moran, supra
note 48, at 403.  Federal restriction did not begin until passage of the 1937 Mari-
huana Tax Act, which placed all Cannabis sativa under the control of the U.S. 
Treasury Department.  Id.
55.Bradley E. Markano, Enabling State Deregulation of Marijuana Through Exec-
utive Branch Nonenforcement, 90 N.Y.U. L. REV. 289, 294 (2015). 
56. Id. 
57.Memorandum from David W. Ogden, Deputy Att¶y Gen., U.S. Dep¶t of Justice, 
to Selected U.S. Att¶ys 1 (Oct. 19, 2009), 
http://www.justice.gov/usao/az/reports/medical-marijuana.pdf.
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DeSDUWPHQW¶V LQYHVWLJDWLYH DQG SURVHFXWRULDO UHVRXUFHV VKRXOG EH
directed towards these objectives. As a general matter, pursuit of 
these priorities should not focus federal resources in your States on 
individuals whose actions are in clear and unambiguous compliance 
with existing state laws providing for the medical use of marijuana.58
,Q VKRUW WKH2JGHQ0HPRVWDWHG WKHJRYHUQPHQW¶V LQWHQW WR VKLIW
federal resources away from Cannabis prosecutions in states that 
permit its use.59
The DEA did not accept the Ogden Memo as a clear mandate.  In 
$SULO LW LVVXHGWKHIROORZLQJSRVLWLRQVWDWHPHQW³:KLOHVRPH
people have interpreted these guidelines to mean that the federal   
government has relaxed LWVSROLF\RQµPHGLFDO¶PDULMXDQDWKLVLQIDFW
is not the case. . . .  [The] DEA will continue to conduct its mission to 
enforce the CSA and other actions as so directed by the U.S.          
AttorQH\*HQHUDO´60
To clarify federal executive policy, on August 29, 2013, Deputy 
Attorney General James M. Cole issued a memorandum to all United 
States Attorneys (the Cole Memo).61  The Cole Memo restated the 
federal governPHQW¶VREMHFWLYH± to target drug traffickers and not to 
LQWHUIHUH ZLWK VWDWHV WKDW HQDFW ³ODZV OHJDOLzing marijuana in some 
form and that have also implemented strong and effective regulatory 
DQG HQIRUFHPHQW V\VWHPV   ´62  The Ogden and Cole Memos       
                                                                                                                          
58.Id. at 1-2. 
59.Id. ³Generally speaking, federal and state governments not only share constitu-
tional jurisdiction over drug crimes, but they have also criminalized largely the 
same behavior. As a practical matter, however, federal authorities play a decidedly 
secondary role.  The overall ratio of federal to state and local law enforcement 
personnel in this country is roughly one to ten, and drug enforcement is not the 
priority it once was.´  Ernest A. Young, Modern-Day Nullification: Marijuana & 
the Persistence of Federalism in an Age of Overlapping Regulatory Jurisdiction, 65 
CASE W. RES. L. REV. 769, 774 (2015) (internal citation omitted). 
60.U.S. DEP¶T OF JUSTICE, DRUG ENFORCEMENT ADMIN., THE DEA POSITION ON 
MARIJUANA 1 (2013), available at
http://www.dea.gov/docs/marijuana_position_2011.pdf, archived at
http://perma.cc/Q4A7-S7RP. 
61.Memorandum from James M. Cole, Deputy Att¶y Gen., to U.S. Att¶ys (Aug. 29, 
2013), http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf. 
62.Id. at 3.
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signaled to the states that the federal government would turn a blind 
eye to Cannabis legalization at the state level. 
As of March 10, 2016, twenty-three states, the District of            
Columbia, and Guam have enacted laws that legalize Cannabis for 
medical use.63  Colorado and Washington were the first to go a step 
further and legalize Cannabis for recreational use.64  In the last     
several years, seventeen other states have passed laws allowing the 
possession of high-CBD, low-THC products (such as CBD oil) for 
various medical conditions.65  The statutes allowing CBD products 
vary in scope from state to state.66  For example, many states, like 
North Carolina, permit possession only for the treatment of epileptic 
conditions.67  Other states, like Georgia, permit possession to treat a 
varieW\ RI FRQGLWLRQV VXFK DV 3DUNLQVRQ¶V GLVHDVH DQG &URKQ¶V
disease.68  Many state statutes either do not define how CBD oil is to 
be obtained, perhaps because those states do not want to set out in 
statute how individuals should violate federal law, or the statutes   
outline complicated and restrictive means of obtaining it.69
Although the Stanley brothers were violating the CSA by growing 
industrial hemp in 2012, they were in compliance with Colorado state 
law, which allowed dispensaries to grow a limited amount of       
                                                                                                                          
63.These states are Alaska, Arizona, California, Colorado, Connecticut, Delaware, 
Hawaii, Illinois, Maine, Maryland, Massachusetts, Minnesota, Michigan, Montana, 
Nevada, New Hampshire, New Jersey, New Mexico, New York, Oregon, Rhode 
Island, Vermont, and Washington.  NATIONAL CONFERENCE OF STATE 
LEGISLATURES, STATE MEDICAL MARIJUANA LAWS (Mar. 10, 2016), 
http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (last visited 
Mar. 18, 2016); MARIJUANA POLICY PROJECT, STATE-BY-STATE MEDICAL 
MARIJUANA LAWS 1 (2015), available at 
http://www.scribd.com/doc/264980279/State-by-State-Laws-Report-2015 (detail-
ing the legality of Cannabis in all 50 states). 
64.NATIONAL CONFERENCE OF STATE LEGISLATURES, supra note 63. Alaska, Ore-
gon, and the District of Columbia also allow Cannabis for recreational use.  Id.
65.These states are Alabama, Florida, Georgia, Iowa, Kentucky, Louisiana, Missis-
sippi, Missouri, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, 
Utah, Virginia, Wisconsin, and Wyoming.  Id.
66. Id. 
67. Id. 
68. Id. 
69. Id. 
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Cannabis sativa.70  Understandably, they were not bold enough to 
grow the amount of industrial hemp needed to satisfy demands for 
the oil, or to distribute it across state lines.71  In a desperate effort to 
obtain the oil, many families moved to Colorado so they could get it 
directly from the Stanleys.72 7KHVHIDPLOLHVZHUHWHUPHG³PDULMXDna 
refuJHHV´DQGGHVSLWHWKHLUZLOOLQJQHVVWRXSURRWWKHLUOLYHVPDQ\RI
them were placed on a waitlist because of the limited supply of the 
oil.73  To assist families in navigating the convoluted process of     
obWDLQLQJ&KDUORWWH¶V:HEWKH6WDQOH\VVWDUWHG a nonprofit, Realm of 
Caring.74  By the end of 2014, there were approximately 12,000   
people nationZLGHRQWKHZDLWOLVWIRU&KDUORWWH¶V:HE75
The Agricultural Act of 2014 
Enactment of the Agricultural Act of 2014, also known as the U.S. 
Farm Bill, marked a significant policy shift with regard to domestic 
industrial hemp cultivation, but it has by no means solved the legal 
conundrum because it does not alter the CSA.76  The U.S. Farm Bill 
provides that industrial hemp may be grown by an institute of higher 
education or a state department of agriculture if: 
(1) the industrial hemp is grown or cultivated for purposes of 
research conducted under an agricultural pilot program or 
other agricultural or academic research; and (2) the growing 
or cultivating of industrial hemp is allowed under the laws of 
the State in which such institution of higher education or State 
department of agriculture is located and such research        
occurs.77
                                                                                                                          
70.See Warner, supra note 31. 
71. Id.
72.Id. (claiming that, as of December 2014, approximately 250 families had      
relocated to Colorado to obtain Charlotte¶s Web).
73. Id. 
74.Id.; About Us, REALM OF CARING, https://www.theroc.us/about-us (last visited, 
Mar. 18, 2016). 
75.Warner, supra note 31. 
76.Agricultural Act of 2014, Pub. L. No. 113-79, § 7606, 128 Stat. 649, 912-13 
(2014). 
77. Id.
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As of March 4, 2016, twenty-eight states have enacted laws related 
to industrial hemp.78  However, some states require a change to the 
CSA or a waiver from the DEA before the programs may be          
implemented.79 ³*HQHUDOO\ VWDWHVKDYH WDNHQ WKUHH DSSURDFKHV 
establish commercial industrial hemp programs[;] (2) establish      
industrial hemp research programs[;] or (3) authorize studies of    
indusWULDOKHPSRUWKHLQGXVWULDOKHPSLQGXVWU\´80
Coinciding with enactment of the U.S. Farm Bill, the Stanleys     
reported that they planned to grow 17 acres of industrial hemp in 
Colorado by the end of 2014, and an estimated 200 acres by 2015.81
Colorado expanded its state laws to allow the cultivation of industrial 
hemp with few restrictions,82 and, although allowing private        
companies to grow unlimited amounts of industrial hemp may not 
meet the plain language restrictions of the U.S. Farm Bill, the bill 
certainly offers a layer of protection.  Additionally, because the     
current administration is turning a blind eye to Cannabis production, 
so long as it complies with state laws, the Stanleys feel confident that 
they will avoid federal prosecution for growing industrial hemp in 
Colorado.83
+RZHYHU WR VDWLVI\ WKHZDLWOLVW IRU&KDUORWWH¶V:HE WKH6WDQOH\V
have to ship the oil across state lines.84  They are currently doing so, 
DQG WKLV PDUNV ³WKH ILUVW WLPH LQ GHFDGHV DQ\RQH has tried to sell    
domestic hemp nationZLGH´85  Now, approximately four years after 
Charlotte Figi tried CBD oil, there is no longer a waitlist for        
CharORWWH¶V:HE86  This good news is tempered by the fact that the 
Stanleys are violating the CSA by distributing a Schedule 1          
controlled substance in interstate commerce.87  While expressing 
                                                                                                                          
78.NATIONAL CONFERENCE OF STATE LEGISLATURES, STATE INDUSTRIAL HEMP 
STATUTES (Mar. 4, 2016), http://www.ncsl.org/research/agriculture-and-rural-
development/state-industrial-hemp-statutes.aspx (last visited, Mar. 19, 2016). 
79. Id. 
80. Id. 
81.Phillips, supra note 26.
82. Id. 
83. Id. 
84. Id. 
85.Id.; REALM OF CARING, supra note 74. 
86.REALM OF CARING, supra note 74. 
87.21 U.S.C. § 841(a)(1).
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WKHLUKRSHWKDW³WKHHQIRUFHPHQWDJHQFLHVKDYHELJJHUILVKWRIU\DQG
GRQ¶WZDQW WR WDNH D EXQFK RIPHGLFLQH DZD\ IURP VLFN NLGV´ WKH
6WDQOH\VDOVRVD\WKDW³>L@I\RXDUHJRLQJWREHORFNHGXSLW¶VDWKLQJ
ZRUWKJHWWLQJORFNHGXSIRU´88
Moreover, to legally possess domestically produced CBD oil under 
the CSA, it must be extracted, sold, and acquired in a state that has 
enacted industrial hemp laws pursuant to the U.S. Farm Bill.89
Consequently, purVXDQWWRWKH&6$LWLVODZIXOWRSRVVHVV&KDUORWWH¶V
Web only in Colorado.90
Contrary to the provisions of the CSA, the 2016 omnibus          
Appropriations Act contains the following language: 
None of the funds made available by this Act or any other Act 
may be used . . . to prohibit the transportation, processing, 
sale, or use of industrial hemp that is grown or cultivated in 
accordance with subsection section 7606 of the Agricultural 
Act of 2014, within or outside the State in which the           
industrial hemp is grown or cultivated.91
Fortunately, this act opens the door to the distribution of CBD oil 
across state lines; however, it is another method of federal           
government nonenforcement and does not alter the CSA. 
Thus far, federal government nonenforcement has prevented     
prosecution for the distribution and possession of CBD oil, and, as 
discussed supra, many states have passed laws to prevent prosecution 
under state law.  However, the CSA remains unchanged.  DEA 
spokeswoman Dearden was right ± that is squishy.   
The Quandary of Imported Industrial Hemp and CBD Oil Derived 
from It 
To add another layer of confusion, while industrial hemp may not 
be grown domestically, except in the limited circumstances described 
                                                                                                                          
88.Phillips, supra note 26 (internal quotation marks omitted).
89.21 U.S.C. § 841(a)(1); Rod Kight, Is CBD Legal?, KIGHT LAW (Oct. 15, 2015), 
http://kightlaw.com/is-cbd-legal/. 
90.See 21 U.S.C. § 841(a)(1). 
91.Consolidated Appropriations Act, 2016 Pub. L. No. 114-113, § 763, 129 Stat. 
2242 (2015). 
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above, hemp products may be imported.92  Approximately thirty 
countries allow the cultivation of industrial hemp.93 ³,URQLFDOO\ WKH
U.S. is the largest importer of [industrial] hemp products in the 
ZRUOG´ ZLWK UHWDLO VDOHV WRWDOLQJ PRUH WKDQ KDOI D ELOOLRQ GROODUV
annually.94
In 2004, Hemp Industries Association (HIA) won a significant     
legal battle against the DEA.95 +,$¶V SURGXFWV ZHUH                    
non-psychoactive hemp products containing trace amounts of        
naturally occurring THC.96  The products were derived from hemp 
plants imported from Canada and Europe.97  In 2003, the DEA 
amended the Code of Federal Regulations to include all naturally 
occurring THC in the definition of THC, a Schedule 1 controlled 
substance listed separately from marijuana.98  The conflict centered 
around the following exemption in the &6$¶V GHILQLWLRQ RI
marijuana: 
Such term does not include the mature stalks of such plant, fi-
ber produced from such stalks, oil or cake made from the 
seeds of such plant, any other compound, manufacture, salt, 
derivative, mixture, or preparation of such mature stalks         
(except the resin extracted therefrom), fiber, oil, or cake, or 
the sterilized seed of such plant which is incapable of         
germination.99
                                                                                                                          
92.Moran, supra note 48, at 408 (³At this time, there are no active federal licenses 
allowing commercial cultivation of industrial hemp.  All commercial hemp prod-
ucts sold in the U.S. are imported or manufactured from imported hemp materi-
als.´); see CBF Info. Ctr., Importing Hemp Products into the U.S., U.S. CUSTOMS 
AND BORDER PROTECTION,
https://help.cbp.gov/app/answers/detail/a_id/1751/~/importing-hemp-products-into-
the-u.s. (last visited, Mar. 20, 2016) (³Hemp products such as paper, rope, and 
clothing (which contain fiber made from the cannabis plant) and animal feed mix-
tures, soaps, and shampoos (which contain sterilized cannabis seeds or oils       
extracted from the seeds), etc. may be imported into the United States.´). 
93.Moran, supra note 48, at 385. 
94.Id. at 387. 
95.Hemp Indus. Ass¶n. v. DEA., 357 F.3d 1012 (9th Cir. 2004). 
96.Id. at 1013 n.2. 
97. Id. 
98.Id. at 1014. 
99.21 U.S.C. § 802(16).
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The Ninth Circuit held that the plain language of the statute         
excluded non-psychoactive hemp products derived IURPWKH³µPDWXUH
VWDONV¶´ RU FRnVWLWXWLQJ ³µRLO RU FDNHPDGH IURP WKH VHHGV¶´ RI WKH
Cannabis plant.100  The DEA was not permitted to enact rules that 
³UHJXODWHnaturally-occurring THC not contained within or derived 
from marijuana²i.e., non-psychoactive hemp products²because 
non-psychoactive hemp is not inFOXGHGLQ6FKHGXOH,´101
In reliance on this decision, manufacturers of CBD oil made from 
imported industrial hemp claim that their products are legal under 
federal law and in all 50 states.102  Others dispute that claim and     
argue that the court in Hemp Industries Association did not consider 
whether CBD was excluded from the CSA.103  The products          
distributed by HIA were derived from sterilized hemp seeds; they 
were not distributing CBD-rich products.104  The case law does not 
FOHDUO\UHVROYHWKLVGLVSXWHDQGWKH'($¶VSRVLWLRQDppears to be that 
all cannabinoids are prohibited under the CSA, including CBD. 
Moreover, questions have been raised about the purity of CBD oil 
derived from imported industrial hemp.105  Some claim that the      
mature stalks of imported industrial hemp contain little CBD, and the 
chemical process used to extract it leaves residual solvents that are 
not fit for human consumption.106  When industrial hemp is grown 
domestically, using Cannabis sativa that has been genetically bred to 
have high-CBD, low-THC concentrations, the oil may be derived 
from the CBD-rich flowers, not just the mature stalks.107
                                                                                                                          
100.Hemp Indus. Ass¶n., 357 F.3d at 1017. 
101.Id. at 1018 (emphasis in original). 
102.Joy Beckerman, The Curious Legal Status of CBD, MARIJUANA VENTURE (Jan. 
1, 2015), http://www.marijuanaventure.com/curious-legal-status-cbd/ (last visited, 
Mar. 20, 2016); Hollie Thrasher, Is CBD Oil Already Legal? (Mar. 19, 2014), 
http://www.waaytv.com/news/is-cbd-oil-already-legal/article_234af87a-afb7-11e3-
8249-0017a43b2370.html (last visited, Mar. 20, 2016). 
103.Beckerman, supra note 102. 
104.See Hemp Indus. Ass¶n., 357 F.3d at 1013. 
105.Beckerman, supra note 102; Kight, supra note 89. 
106.Beckerman, supra note 102; Kight, supra note 89. 
107.Kight, supra note 89.  The Realm of Caring offers the following information 
on its website: ³Colorado grown Charlotte¶V :HE KHPS KDV EHHQ EUHG WR EH   
naturally rich in CBD while being very low in THC.  This offers a significant    
advantage when compared to other CBD products on the market today - most of 
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Consequently, the uncertain legal status of CBD made from          
domestically grown industrial hemp may have created a market for a 
potentially dangerous imported product. 
PART THREE: LIMITATION ON RESEARCH EFFORTS
To date, the efficacy of CBD oil is largely anecdotal.108  Most   
studies involve parental reporting of dosage and reduction of         
seizures.109  In 2015, researchers at the University of California, Los 
Angeles (UCLA) reported that 85 percent of study participants 
claimed a reduction in seizure frequency after using CBD oil.110
However, the researchers admit that the primary limitation in their 
study is that it was conducted via an online-administered survey, as 
opposed to a controlled study where dosage and seizure control could 
be monitored.111  The report concludes by stating: 
At face value, this study indicates that CBD-containing products 
might be effective and well tolerated in the treatment of multiple 
forms of refractory childhood epilepsy[,] . . . but enthusiasm must be 
tempered by the absence of controlled data supporting this view.  
Rigorous clinical trials are clearly warranted and supported by these 
findings to determine the efficacy and safety of CBD.112
                                                                                                                          
which are derived from imported foreign hemp pastes from industrial hemp strains 
that are very low in CBD. . . .  Hemp is known to pull toxic heavy metals such as 
lead and arsenic from soils.  In fact, hemp is sometimes used as a remediation crop 
to decontaminate polluted soils.  By extracting CBD from industrial hemp strains 
that contain only trace levels of CBD, other manufactures are required to use poten-
tially ten to twenty times the amount of plant material to obtain the same amount of 
CBD that could be extracted from a single Charlotte¶V :HE SODQW  :LWK WHQ
times the plant material, you are also potentially ingesting ten times whatever else 
was in that soil.   Because Charlotte¶V:HELVSURXGO\JURZQRQWKHDULGSODLQVRI
Colorado on family farms, we are able to know the history of our farmland.´
REALM OF CARING, supra note 74. 
108.The Realm of Caring website provides many success stories.  REALM OF 
CARING, supra note 74. 
109.See Shaun A. Hussain et al., Perceived Efficacy of Cannabidiol-enriched   
Cannabis Extract for Treatment of Pediatric Epilepsy: A Potential Role for       
Infantile Spasms and Lennox-Gastaut Syndrome, 47 EPILEPSY & BEHAVIOR 138, 
138 (2015). 
110.Id. 
111.Id. 
112.Id.
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In another 2015 study, researchers conducted a retrospective chart 
UHYLHZRIFKLOGUHQZKRKDGEHHQWUHDWHGDWWKH&KLOGUHQ¶V+RVSLWDORI
Colorado.113  The children had documented seizure frequency prior to 
taking CBD oil as a daily treatment.114  The study states that,          
according to parental reporting, 57 percent of the children showed at 
least some reduction in seizures, and 33 percent had a greater than 50 
percent reduction in seizures.115  Like the UCLA researchers, the     
researchers in this study acknowledge challenges with parental      
reporting as opposed to controlled studies.116  In conclusion, the    
reSRUW VWDWHV ³:H VWURQJO\ VXSSRUW WKH QHHG IRU FRQWUROOHG EOLQGHG
studies to evaluate the efficacy and safety of OCE [Oral Cannabis
Extracts] for treatment of pediatric epilepsies. . . .  This study        
provides . . . evidence that OCE is well tolerated by children and    
adolesFHQWVZLWKHSLOHSV\´117
As these studies indicate, additional research is needed.             
Controlled, blind studies are imperative to assess the efficacy of CBD 
oil and to create guidelines for CBD concentrations and dosage     
instructions.118  However, in order to conduct federally sanctioned 
research, scientists must obtain approval from the Food and Drug 
Administration (FDA), the DEA, and the National Institute of Drug 
Abuse.119  In 2014, Colorado set aside $9 million to research the    
efficacy of Cannabis, and one of the proposed studies focuses on DS 
and the efficacy of CBD oil.120  Colorado researchers acknowledge 
                                                                                                                          
113.Press, supra note 2, at 49. 
114.Id. at 50. 
115.Id.
116.Id. at 52. 
117.Id. 
118.See id. 
119.J. Herbie DiFonzo et al., Divided We Stand: Med. Marijuana & Federalism, 27 
HEALTH LAW 17, 20 (June 2015).  As of 2013, the DEA reported that ³[t]here are 
125 researchers registered with DEA to perform studies with marijuana, marijuana 
extracts, and non-tetrahydrocannabinol marijuana derivatives that exist in the plant, 
such as cannabidiol and cannabinol.´ THE DEA POSITION ON MARIJUANA, supra
note 60, at 5. 
120.John Ingold, Colorado Medical Marijuana Research Grants Face Federal 
Uncertainty, THE DENVER POST (Aug. 29, 2014), 
http://www.denverpost.com/news/ci_26433404/colorado-medical-marijuana-
research-grants-face-federal-uncertainty.  The study is titled ³Genetic Analysis 
Between Charlotte¶s Web Responders Versus Non-Responders in a Dravet        
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that getting DEA approval for Cannabis studies is a time consuming 
process.121 ³µ<RX FDQ GR LW    EXW \RXKDYH WR MXPS WKURXJK WKH
KRRSV¶´122  Children suffering from DS do not have time for         
researchers to jump through hoops.  This process needs to be      
streamlined by eliminating the Schedule 1 designation for industrial 
hemp.123
PART FOUR: RECOMMENDATION FOR FEDERAL LEGISLATION
Cannabis law is a patchwork of inconsistent federal and state laws, 
coupled with government nonenforcement of these laws, which     
creates instability in an area where lives are at stake.  While federal 
nonenforcement has allowed better access to CBD oil, it is not a 
permanent solution.  A new Attorney General could change the    
                                                                                                                          
Population´ and is being conducted at the University of Colorado, Denver. 
CLINICAL TRIALS.GOV,
https://www.clinicaltrials.gov/ct2/show/NCT02229032?term=dravet&rank=1 (last 
visited, Mar. 20, 2016). 
121.Ingold, supra note 120. 
122.Id. 
123.This article is not intended to promote CBD oil produced from industrial hemp, 
such as Charlotte¶s Web, over a pharmaceutical alternative.  GW Pharmaceuticals 
has acquired orphan drug status and fast track designation for its drug, Epidiolex, 
³[a] liquid formulation of pure plant-derived Cannabidiol.´  Therapeutic Areas, 
GW PHARMACEUTICALS, http://www.gwpharm.com/therapeutic-areas.aspx (last 
visited Apr. 18, 2016).  GW Pharmaceuticals recently issued a press release, stating 
that in Phase 3 clinical trials, ³patients taking Epidiolex achieved a median reduc-
tion in monthly convulsive seizures of 39 percent compared with a reduction on 
placebo of 13 percent[.]´  Press Release, GW Pharmaceuticals, GW Pharmaceuti-
cals Announces Positive Phase 3 Pivotal Study Results for Epidiolex (Cannabidiol) 
(Mar. 14, 2016), 
http://www.gwpharm.com/GW%20Pharmaceuticals%20Announces%20Positive%
20Phase%203%20Pivotal%20Study%20Results%20for%20Epidiolex%20cannabid
iol.aspx.  Epidiolex may seek FDA approval later this year.  Julie Carr Smyth, 
Medical Pot Activists Fear Epilepsy Drug Could Undercut Them, ASSOCIATED 
PRESS, Apr. 17, 2016, 2016 WL AP Alerts 16:09:23  ³Many medical marijuana 
activists fear Epidiolex approval will mark the beginning of Big Pharma¶s takeover 
of the marijuana plant, undercutting patients¶ ability to treat themselves as they see 
fit.´ Id.  To the contrary, this author is not a medical marijuana activist and hopes 
to see more options to treat DS.  Epidiolex is promising, but does not eliminate the 
need for research into CBD oil produced from domestically grown industrial hemp, 
which has also shown promise in treating DS. 
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executive policy set by the Cole and Ogden Memos.124  Even while 
the policy is in effect, it is only policy, not law.125 $³GLVREHGLHQW´
federal prosecutor may choose instead to enforce the letter of the    
federal law.126 ,QIDFW³WKHUHLVWUHPHQGRXVYDULDWLRQLQHQIRUFHPHQW
SROLF\ IURPRQH86$WWRUQH\¶VRIILFH WR WKHQH[W, including in the 
FRQWH[WRIGUXJHQIRUFHPHQW´127
With varying federal policies, the landscape is unclear, even to law 
enforcement.  In 2014, the DEA seized a shipment of industrial hemp 
seeds in route to Kentucky that the state contends was permitted    
under the U.S. Farm Bill.128  Kentucky Agriculture Commissioner 
-DPHV &RPHU VWDWHG WKDW WKH '($ ZDV ³µLQWHUSUHWLQJ WKH ODZ D
hunGUHGGLIIHUHQWZD\V>@¶´129  The solution is a definitive change to 
the CSA that would permit uninhibited industrial hemp cultivation in 
this country and expressly exclude CBD from the definition of       
marijuana. 
7KH &KDUORWWH¶V :HE 0HGLFDO $FFHVV $FW RI  LV FXUUHQWO\
SHQGLQJ LQ &RQJUHVV DQG H[FOXGHV ³>F@DQQDELGLRO DQG
cannabidiol-ULFKSODQWV´IURPWKHGHILQLWLRQRI³PDULKXDQD´7KH$FW
deILQHV³FDQQDELGLRO-ULFKSODQWV´DVKDYLQJQRWPRUHWKDQSHUFHQW
THC.130 ,WLVXQFOHDUZK\WKHELOOFUHDWHVWKHQHZWHUP³FDQQDELGLRO-
ULFK SODQWV´  7R DYRLG FRQIXVLRQ WKH ELOO VKRXOG XVH WKH WHUP
³LndusWULDOKHPS´
Additionally, the bill states that ³>W@KH )HGHUDO )RRG 'UXJ DQG
Cosmetic Act . . . shall not apply to cannabidiol or cannabidiol-rich 
SODQWV   ´131  Complete removal of FDA oversight of CBD oil is 
unwise.  In 2015, the FDA sent letters to seven companies that sell 
CBD oil, warning them that the products were not recognized as safe 
                                                                                                                          
124.Alex Kreit, What Will Fed. Marijuana Reform Look Like?, 65 CASE W. RES. L.
REV. 689, 693 (2015). 
125.Id. at 694. 
126.Id. 
127.Markano, supra note 55, at 312. 
128.Ryan Grim & Matt Ferner, DEA Seizes Kentucky¶s Hemp Seeds Despite Con-
gressional Legalization, HUFFINGTON POST (May 14, 2014), 
http://www.huffingtonpost.com/2014/05/13/dea-seizes-kentuckys-
hemp_n_5318098.html. 
129.Id. 
130.Charlotte¶s Web Medical Access Act of 2015, H.R. 1635, 114th Cong. (2015). 
131.Id.
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and that they were engaging in illegal interstate commerce.132
Accompanying the letters were lab results showing that the CBD 
concentration in the oils was lower than advertised.133 7KH)'$¶V
enforcement efforts were welcomed by CBD oil advocates like Paige 
)LJL ZKR VDLG ³>W@KH\¶UH FUDFNLQJ GRZQ RQ TXDOLW\ ZKLFK LV         
extremeO\ LPSRUWDQW DQG ,¶P YHU\ KDSS\>@´134  A more prudent    
approach, therefore, would be limited FDA oversight of quality 
measures, such as CBD concentration. 
Although some adjustments to the bill should be made, this article 
supports its passage.  This legislation has bipartisan support and its 
enactment will respond to the needs of families struggling with DS. 
CONCLUSION
Discussing the legalization of CBD oil and industrial hemp should 
not evoke concerns that it will be a slippery slope leading to the     
legalization of recreational marijuana.  The marijuana debate can and 
should be left for another day.  Rather, the merits of CBD oil        
produced from industrial hemp should be considered in isolation as a 
distinct, non-psychoactive substance.  The potential medical benefit 
is not merely speculative; it has been seen in the stories of Charlotte 
Figi and other children like her.  More research is needed to assess its 
efficacy, but in order to engage in that research, the legal barriers 
must come down. 
                                                                                                                          
132.Steven Nelson, FDA Brings Down Hammer on CBD Companies, U.S. NEWS &
WORLD REPORT (Mar. 11, 2015), 
http://www.usnews.com/news/articles/2015/03/11/fda-brings-down-hammer-on-
cbd-companies. 
133.Id. 
134.Id.
